| Literature DB >> 35292849 |
Shaza Abo1,2, Selina M Parry3, David Ritchie4, Gabriella Sgro5, Dominic Truong3, Linda Denehy3,6, Catherine L Granger3,5.
Abstract
PURPOSE: Exercise is emerging as a vital aspect of care to alleviate the physical and psychosocial symptom burden associated with allogeneic bone marrow transplantation (BMT). Understanding the patient perspective regarding exercise is important to move towards implementation. This study aimed to characterise experiences and views regarding participation in an exercise program in adults receiving treatment for haematological disease with allogeneic BMT.Entities:
Keywords: Allogeneic bone marrow transplantation; Exercise; Patient experience; Quality of life; Stem cell transplantation; Survivorship
Mesh:
Year: 2022 PMID: 35292849 PMCID: PMC9046308 DOI: 10.1007/s00520-022-06931-9
Source DB: PubMed Journal: Support Care Cancer ISSN: 0941-4355 Impact factor: 3.359
Fig. 1Participant recruitment from each intervention study to the qualitative study
Summary of the two exercise programs
| Time | Early-commencing inpatient exercise program[ | Late-commencing outpatient exercise program[ |
|---|---|---|
| Pre-transplant | Assessment with physiotherapist + physical activity advice | Assessment with physiotherapist + physical activity advice |
| During inpatient hospital stay for transplant | Superviseda on BMT unit of hospital: 1 h, 5 days/week Unsupervised: 2 days/week | Nil |
| Hospital discharge to day 60 post-transplant | Unsupervised home-based exercise program, goal to complete 3–5 days/week; 1 day/week phone calla to encourage + progress exercise as needed | Nil |
| Day 60 to approximately day 100 post-transplant | Study ceased at day 60; participants continued with routine care which by this stage included an outpatient exercise program | Superviseda: in outpatient hospital gymnasium for 1 h, 1 day/week Unsupervised: home-based program, goal to complete 3–5 days/week |
| Type and intensity of exercise | Group-based; mixed aerobic and resistance; individualised at low-moderate intensity | Group-based; mixed aerobic and resistance; individualised at moderate intensity |
| Exercise “tools” | Exercise diary × 2: (1) to complete during inpatient admission; (2) to complete from discharge to 60 days post-transplant | Provision of “FitBit” activity tracker and exercise diary to complete from day 60 to day 100 post-transplant |
aSupervised exercise sessions and follow-up phone calls were led by a physiotherapist with expertise in oncology care
Demographics of participants from the inpatient and outpatient studies who did or did not provide qualitative data
| Participants of the early-commencing inpatient study | Participants of the late-commencing outpatient study | |||
|---|---|---|---|---|
| Provided qualitative data ( | Did not provide qualitative data ( | Provided qualitative data ( | Did not provide qualitative data ( | |
| Age at baseline, mean (SD) (years) | 46.9 (12.6), range 24–64 | 52.9 (14.0), range 27–72 | 44.0 (13.4), range 21–65 | 46.4 (15.2), range 18–68 |
| Sex, male (%) | 10 (62.5) | 19 (73.1) | 10 (52.6) | 16 (66.7) |
| BMI (kg/m2) | 27.2 (5.9) | 27.3 (4.0) | 26.2 (5.5) | 26.3 (4.7) |
| Diagnosis, | ||||
| - AML | 5 (31.3) | 10 (38.5) | 11 (57.9) | 13 (54.2) |
| - B-ALL | 2 (12.5) | 6 (23.1) | 1 (5.3) | 2 (8.3) |
| - MM | 3 (18.8) | 1 (3.8) | 4 (21.1) | 0 |
| - ALL | 2 (12.5) | 2 (7.7) | 0 | 2 (8.3) |
| - T-ALL | 3 (18.8) | 2 (7.7) | 0 | 1 (4.2) |
| - MDS | 0 | 1 (3.8) | 1 (5.3) | 3 (12.5) |
| - T-Cell LGLL | 1 (6.3) | 2 (7.7) | 1 (5.3) | 0 |
| - AA | 0 | 1 (3.8) | 0 | 2 (8.3) |
| - CML | 0 | 1 (3.8) | 0 | 1 (4.2) |
| Allogeneic transplant type | ||||
| - Sibling or related donor | 6 (37.5) | 6 (23.1) | 9 (47.4) | 6 (30) |
| - MUD | 6 (37.5) | 13 (50) | 9 (47.4) | 14 (70) |
| - Cord | 1 (6.3) | 0 | 1 (5.3) | 0 |
| - Haploidentical | 3 (18.8) | 7 (26.9) | 0 | 0 |
| Meeting physical activity guidelines pre-transplant, | 12 (75) | 16 (64), | 12 (70.6), | 15 (68.2), |
| Attendance at group-based exercise program (%)b | 62%, from | 55%, from | 72%, from | 57%, from |
aExcept where specified that sample was lower due to missing data
bAttendance is reported as a percentage of sessions attended out of total scheduled sessions
Abbreviations: AA, aplastic anaemia; ALL, acute lymphoblastic leukaemia; AML, acute myeloid leukaemia; B-ALL, B-cell acute lymphoblastic leukaemia; CML, chronic myeloid leukaemia ; BMI, body mass index; MDS, myelodysplastic syndrome; MM, multiple myeloma; MUD, matched unrelated donor; T-ALL, T-cell acute lymphoblastic leukaemia; T-Cell LGLL, T-cell large granular lymphocytic leukaemia
Fig. 2Summary of the major themes and sub-themes developed from participant perspectives. Three of the six major themes linked strongly to the COM-B model [26]